|Bid||235.70 x 800|
|Ask||235.94 x 1300|
|Day's Range||235.38 - 244.74|
|52 Week Range||98.02 - 252.45|
|Beta (5Y Monthly)||1.04|
|PE Ratio (TTM)||14.83|
|Earnings Date||Apr 27, 2021 - May 03, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Mar 29, 1994|
|1y Target Est||269.85|
Event-driven investment firm releases quarterly portfolio
Shares of Walgreens Boots Alliance Inc. gained 0.3% in trading on Thursday, the day after the pharmacy giant said it will begin selling over-the-counter COVID-19 tests developed by the Laboratory Corporation of America Holdings . Labcorp's stock was down 1.8%. The at-home PCR test kits will be sold at pharmacy counters in an estimated 6,000 Walgreens stores in the U.S. sometime this spring, allowing people to buy a kit, self-administer a nasal swab, and mail the sample back to Labcorp via FedEx. People do not need a prescription to purchase the test kit. A Walgreens spokesperson said in an email that it is not disclosing the price of the test at this time. Over the past 12 months, Walgreen's stock has gained 4.1% and shares of Labcorp are up 29.9%. The S&P 500 is up 21.7%.
As part of Walgreens ongoing efforts to increase access to COVID-19 testing in communities across the U.S., the company announced today it has entered into an agreement with Labcorp™ to sell Pixel by Labcorp COVID-19 PCR Test Home Collection Kits over-the-counter in up to 6,000 Walgreens stores nationwide beginning in spring of this year. Walgreens is making significant strides to increase on-site testing capacity at more than 5,000 Walgreens pharmacy locations by April 1, with more than half of sites located in socially vulnerable areas.